Summary
We have prepared antibody/3H-dsDNA immune complexes and have used three independent radio-immunoassays to quantitate their interaction with complement; the solution phase C1q assay, the Raji cell assay, and a complement-based red blood cell adherence assay (RBC-CF). Our results indicate that although there is reasonable qualitative agreement between the Raji cell assay and the RBC-CF assay, there are some differences in the quantitative range of sensitivities of the two assays. On the other hand, we find that most of the complement-fixing antibody/3H-dsDNA complexes are not detected in the solution phase C1q assay. The results suggest this is because the absolute concentrations of the immune complexes were too low to achieve significant precipitation under the standard conditions used in the C1q assay. The implication of these findings with respect to the potential detection and analysis of antibody/dsDNA immune complexes is discussed.
Similar content being viewed by others
References
Rothfield NF, Stollar BD (1967) The relation of immunoglobulin class, pattern for anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus. J Clin Invest 46: 1785–1794
Agnello V, Koffler D, Kunkel HG (1973) Immune complex systems in the nephritis of systemic lupus erythematosus. Kidney Int 3:90–99
Koffler D (1974) Immunopathogenesis of systemic lupus erythematosus. Annu Rev Med 25:149–165
Sontheimer RD, Gilliam JW (1978) DNA antibody class, subclass, and complement fixation in systemic lupus erythematosus with and without nephritis. Clin Immunol Immunopathol 10:459–467
Ballou SP, Kushner I (1979) Immunochemical characterization of antibodies to DNA in patients with active systemic lupus erythematosus. Clin Exp Immunol 37:58–67
Beaulieu A, Quismorio FP, Kitridou RC, Friou GJ (1979) Complement fixing antibodies to ds-DNA in systemic lupus erythematosus. J Rheumatol 6:389–396
Minter MH, Stollar BD, Agnello V (1979) Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus. Arthritis Rheum 22:959–966
Aarden LA, Groot ER de, Feltkamp TEW (1975) Immunology of DNA III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann NY Acad Sci 254:505–515
Stollar BD (1977) Quantitative microcomplement fixation and radioactive antigen binding assays for measuring anti-DNA antibodies. Ann Rheum Dis 36: Suppl 102–107
Theofilopoulos AN, Dixon FJ (1980) The biology and detection of immune complexes. Adv Immunol 28:89–220
Tsuda F, Miyakawa Y, Mayumi M (1979) Application of human erythrocytes to a radioimmune assay of immune complexes in serum. Immunology 37:681–688
Taylor RP, Pederson SE, Morley KW, Wright EL (1980) Kinetic control of complement fixation in DNA/anti-DNA complexes (Abstract). Arthritis Rheum 23:755
Pedersen SE, Taylor RP, Morley KW, Wright EL (1980) Stability of DNA/anti-DNA complexes IV. Complement fixation. J Immunol Methods 38:269–280
Theofilopoulus AN, Wilson CB, Dixon FJ (1976) The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest 57:169–182
Nydegger UE, Lambert PH, Gerber H, Miescher PA (1974) Circulating immune complexes in the serum in system lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q. J Clin Invest 54: 297–309
Zubler RH, Lange G, Lambert PH, Miescher PA (1976) Detection of immune complexes in unheated sera by a modified 125I-C1q binding test. Effect of heating in the binding of C1q by immune complexes and application of the test to systemic lupus erythematosus. J Immunol 116:232–235
Riley RL, Addis DJ, Taylor RP (1980) Stability of DNA/anti-DNA complexes. II. Salt lability and avidity. J Immunol 123:1–7
Waller SJ, Taylor RP, Wright EL, Morley KW, Johns M (1981) DNA/anti-DNA complexes: Correlation of size and complement fixation. Arthritis Rheum (in press)
Hay FC, Nineham LJ, Roitt IM (1976) Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q. Clin Exp Immunol 24:396–400
Anderson CL, Stillman WS (1980) Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus. J Clin Invest 66:353–360
Fine DP, Marney SR, Colley DG, Sergent JS, Des Prez RM (1972) C3 shunt activation in human serum chelated with EGTA. J Immunol 109:807–809
Platts-Mills TA, Ishizaka K (1974) Activation of the alternate pathway of human complement by rabbit cells. J Immunol 113:348–358
Inman RD, Fong JKK, Pussel BA, Ryan PJ, Hughes GRV (1980) The C1q binding assay in systemic lupus erythematosus: disordance with disease activity. Arthritis Rheum 23:1282–1286
Sobel AT, Bokisch VA (1975) Receptor for C1q on peripheral human lymphocytes and human lymphoblastoid cells. Fed Proc (Abstract) 34:965
Theofilopoulos AN, Bokisch VA, Dixon FJ (1974) Receptor for soluble C3 and C3b on human lymphoblastoid (Raji) cells. J Exp Med 139:696–711
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taylor, R.P., Andrews, B.S., Morley, K.W. et al. Quantitative studies of the interaction of 3H-dsDNA/anti-DNA immune complexes with complement: Comparison and evaluation of the Raji cell, the solution phase C1q, and the red blood cell linked complement fixation radioimmunoassays. Rheumatol Int 1, 29–34 (1981). https://doi.org/10.1007/BF00541220
Issue Date:
DOI: https://doi.org/10.1007/BF00541220